Biotech startups are built on venture capital. Track funding rounds here.

Autor:	Wu, Gwendolyn, Fidler, Ben, Pagliarulo, Ned, Himmel, Julia
Předmět:	NEW business enterprises DRUG discovery VENTURE capital companies BANKING industry BIOTECHNOLOGY industries VENTURE capital
Zdroj:	BioPharma Dive; 11/21/2024, pN.PAG-N.PAG, 1p
Abstrakt:	The article discusses the crucial role of venture capital in supporting biotech startups, which are often years away from profitability. Venture capitalists invest millions of dollars in these companies to help them reach key milestones like clinical testing. The database compiled by BioPharma Dive tracks funding rounds involving 23 active venture capital firms, revealing trends in investment patterns across different drug types and diseases. The article also highlights the shift towards later-stage biotechs and the increasing size of funding rounds in 2024 compared to previous years. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.